Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PAYS US Equity

Paysign, Inc.Industrials · Services-Business Services, NEC · CIK 1496443 · FY ends Dec 31
$14.09
+0.27 (+1.95%)
USD · as of 2026-08-21 · marketstack

PAYS · 10-K · period ended 2021-12-31

← all PAYS documents
filed 2022-03-23 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 1600 of 1,966173k characters rendered

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-K

(Mark One)

☒ANNUAL

REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

☐TRANSITION

PURSUANT TO UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number 001-38623

PAYSIGN, INC.

(Exact name of registrant as specified in its charter)

2615 St. Rose Parkway, Henderson, Nevada89052

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including

area code: (702)453-2221

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class Trading Symbol Name of each exchange on which registered

Common Stock, $0.001 par value per share PAYS The Nasdaq Stock Market LLC

Securities registered under Section 12(g) of the

Exchange Act: None

Indicate

by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

Indicate

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate

by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange

Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has

been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate

by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule

405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant

was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated

filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of

“large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth

company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐

Non-accelerated filer ☒ Smaller reporting company ☒

Emerging growth company ☒

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate

by check mark whether the registrant has filed a report and attestation to its management’s assessment of the effectiveness of

its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262 (b)) by the registered public

accounting firm that prepared or issued its audit report. ☐

Indicate

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

State the aggregate market value of the voting

and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the

average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second

fiscal quarter: $100,192,362 based upon a market price of $3.18 per share.

Indicate the number of shares outstanding of each

of the registrant’s classes of common stock, as of the latest practicable date: 51,864,932 as of March 17, 2022.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive

Proxy Statement for its 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form

10-K where indicated. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant's

fiscal year ended December 31, 2021.

TABLE OF CONTENTS

PART I 1

ITEM 1 BUSINESS. 1

ITEM 1A. RISK FACTORS. 10

ITEM 1B. UNRESOLVED STAFF COMMENTS. 18

ITEM 2. PROPERTIES. 19

ITEM 3 LEGAL PROCEEDINGS. 19

ITEM 4. MINE SAFETY DISCLOSURE. 19

ITEM 6. [RESERVED]. 20

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES OF MARKET RISK. 28

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. 28

ITEM 9A. CONTROLS AND PROCEDURES. 28

ITEM 9B. OTHER INFORMATION. 29

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS. 29

PART III 30

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. 30

ITEM 11. EXECUTIVE COMPENSATION. 30

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES. 30

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES. 31

SIGNATURES 33

Note Regarding Forward Looking Statements

This Annual Report on Form 10-K contains "forward-looking

statements." These forward-looking statements are based on our current expectations, assumptions, estimates and projections about

our business and our industry. Words such as "believe," "anticipate," "expect," "intend," "plan,"

“propose,” "may," and other similar expressions identify forward-looking statements. In addition, any statements

that refer to expectations, projections, estimates, forecasts, or other characterizations of future events or circumstances are forward-looking

statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ

materially from those reflected in the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking

statements, which relate only to events as of the date on which the statements are made. We undertake no obligation to publicly revise

these forward-looking statements to reflect events or circumstances that arise after the date hereof. You should refer to and carefully

review the information in future documents we file with the Securities and Exchange Commission.

i

PART

I

ITEM

1. BUSINESS.

Overview

Paysign, Inc. (the “Company,” “Paysign,”

“we” or “our”), headquartered in Nevada, was incorporated on August 24, 1995, and trades under the symbol PAYS

on The Nasdaq Stock Market LLC. Paysign is a vertically integrated provider of prepaid card products and processing services for corporate,

consumer and government applications. Our payment solutions are utilized by our corporate customers as a means to increase customer loyalty,

increase patient adherence rates, reduce administration costs and streamline operations. Public sector organizations can utilize our payment

solutions to disburse public benefits or for internal payments. We market our prepaid card solutions under our Paysign® brand. As

we are a payment processor and prepaid card program manager, we derive our revenue from all stages of the prepaid card lifecycle.

We provide a card processing platform consisting

of proprietary systems and software applications based on the unique needs of our clients. We have extended our processing business capabilities

through our proprietary Paysign platform. Through the Paysign platform, we provide a variety of services including transaction processing,

cardholder enrollment, value loading, cardholder account management, reporting, and customer service. The Paysign platform was built on

modern cross-platform architecture and designed to be highly flexible, scalable and customizable. The platform’s flexibility and

ease of customization has allowed us to expand our operational capabilities by facilitating our entry into new markets within the payments

space. The Paysign platform delivers cost benefits and revenue building opportunities to our partners.

We have developed prepaid card programs for corporate

incentive and rewards including, but not limited to, consumer rebates and rewards, donor compensation, clinical trials, healthcare reimbursement

payments and pharmaceutical payment assistance. We have expanded our product offerings to include additional corporate incentive products

and demand deposit accounts accessible with a debit card. In the future, we expect to further expand our product offerings into other

prepaid card offerings such as payroll cards, travel cards, and expense reimbursement cards. Our cards are sponsored by our issuing bank

partners.

Our revenues include fees generated from cardholder

fees, interchange, card program management fees, and settlement income. Revenue from cardholder fees, interchange and card program management

fees is recorded when the performance obligation is fulfilled. Settlement income is recorded at the expiration of the card program.

What Are Prepaid Cards?

A prepaid card is a payment product that is pre-funded

and not directly linked to an individual bank account. Prepaid cards are unlike debit cards that are attached to a personal or business

checking account and draw funds from that linked account or a credit card that draws funds from a line of credit.

Prepaid cards can either be open-loop, closed-loop,

or restricted-loop. Open-loop, or network-branded, prepaid cards carry an acceptance mark of a national or international payment network

such as Visa, Interlink, Plus, MasterCard, Maestro, Cirrus, Discover or Pulse and can be used anywhere that card brand is accepted. Closed-loop

prepaid cards can only be used at a specific merchant whose name is typically branded on the card and are most likely not network branded.

Restricted-loop prepaid cards may carry a network brand and can be used only at a specific group of non-affiliated merchant locations

such as a shopping mall or a specific merchant category.

Open-loop, and some restricted-loop, prepaid cards

are issued by a financial institution under a license of the payment network. Open-loop prepaid cards provide consumers, businesses and

governments with the efficiency, security and flexibility of digital payments reducing costs associated with handling cash, checks and

other paper-based payment processes, and provides the end user a payment product that is accessible and with global utility, convenient,

safer than cash, can be used as a budgeting tool and contains protections against fraud and theft.

The prepaid market continues to experience significant

growth due to consumers, corporations and governments embracing improved technology, greater convenience, more product choices and greater

flexibility. Prepaid cards have also proven to be an attractive alternative to traditional bank accounts for certain segments of the population,

particularly those without, or who could not qualify for, a checking or savings account.

The Mercator Advisory Group’s 18th

Annual U.S. Open-Loop Prepaid Cards Market Forecast 2021-2025, shows that “2020 has been an extraordinary year for prepaid card

loads as a result of government benefits in response to COVID-19. As these benefits subside, 2021 will see an initial drop in load values

followed by steady growth.” Mercator forecasts open-loop prepaid card loads will have a compound annual growth rate of 3.0% from

2021 to 2025, when total loads are expected to reach $735 billion.

Consumers, both banked and unbanked, use prepaid

cards such as general purpose reloadable (“GPR”) cards, to conduct their day-to-day financial transactions such as paying

bills, depositing checks, and receiving direct deposits. According to the 2019 FDIC Survey of Household Use of Banking and Financial Services,

8.5% of U.S. households or approximately 128 million households, use GPR prepaid cards.

Common Examples of Prepaid Cards

The prepaid card market is divided into three

macro categories based on who funds the card account. These categories are consumer-funded, corporate-funded and government-funded.

Consumer-Funded Programs: The consumer

prepaid category consists of products such as GPR cards, gift cards, travel money cards, and remittance/peer-to-peer (“P2P”)

cards.

General Purpose Reloadable Cards: A

type of prepaid card typically purchased by a consumer for his/her personal use to pay for purchases, pay bills and/or access cash at

ATMs. GPR cards may be purchased online and in retail locations from a variety of providers. Funds may be loaded onto the card by direct

deposit of wages or benefits or at retail locations offering prepaid card reload services.

Gift Cards: A non-reloadable

prepaid card that is purchased by a gift giver to be given to a gift recipient.

Corporate-Funded Programs: The corporate

prepaid category consists of products such as employee/partner incentives, consumer incentives, payroll, employee benefits, healthcare,

corporate expense and business travel, insurance claim disbursement, etc.

Our Products and Services

As a payment processor and prepaid card program

manager, our payment solutions are utilized by our customers as a means to increase customer loyalty, increase brand recognition, reward

customers, agents and employees while reducing administration costs and streamlining operations. We manage all aspects of the prepaid

card lifecycle, from the card design and approval processes with partners and networks, to production, packaging, distribution, and personalization.

We also oversee inventory and security controls, renewals, and lost and stolen card management and replacement. We provide in-house customer

service which includes live bilingual customer care representatives staffed 24/7/365. We also run in-house Interactive Voice Response

(“IVR”) and two-way short message service (“SMS”) messaging platforms. As we do not have our own banking license

to issue open-loop prepaid cards, our cards are offered to end users through our relationships with bank issuers.

As an end-to-end payment processor and prepaid

card program manager, we derive our revenue from all stages of the card lifecycle. These revenues can include fees from program set-up;

customization and development; data processing and report generation; card production and fulfillment; transaction fees derived from card

usage; inactivity fees; card replacement fees; program administration fees; and settlement income.

To date, we have issued millions of prepaid cards

under programs implemented for Fortune 500 companies, multinationals, as well as top pharmaceutical manufacturers, universities and social

media companies.

As of December 31, 2021, we had approximately

4.3 million cardholders participating in approximately 440 card programs.

In our early years of operations, we focused mainly

on providing co-pay assistance prepaid cards to the pharmaceutical industry. In 2011, we began marketing a corporate incentive prepaid

card-based payment solution targeting the plasma donation industry. More recently, having built the necessary infrastructure and added

essential staff, we have increased our focus and sales efforts on corporate incentive and corporate expense card programs as well as retargeting

the pharmaceutical industry with co-pay assistance, buy and bill and other prepaid programs designed to maximize patient enrollment, adherence

and retention.

The Paysign®Brand

In order to leverage the capabilities of the Paysign

platform and successfully expand our product offerings, we established the Paysign brand of prepaid cards and solutions. The Paysign brand

encompasses all of our current and future prepaid product offerings, including but not limited to, corporate incentives, healthcare related

payment solutions for clinical trials, donations and co-pay assistance, payroll, settlement payments, corporate expense cards and solutions

designed for the public sector as well as general purpose reloadable prepaid cards. Paysign is a registered trademark of the Company in

the United States and other countries.

Corporate Incentives

Our Paysign corporate incentive cards offer businesses

a practical and contemporary way to reward and motivate existing and potential customers, employees, donors, patients, clinical trial

participants, sales professionals, agents and distributors. We develop incentive card programs, either traditional plastic or virtual,

that our customers use for a wide variety of applications, including but not limited to: consumer rebates for large purchases or frequent

buyers; trade incentives for third party distributors; new product launches and commission based sales incentives; consumer promotions

such as automobile test drives; purchase incentives; loyalty rewards; compensation for the time and effort of donating; pharmaceutical

payment assistance; referral programs; event giveaways; and purchase incentives. The Paysign solution can be integrated into existing

payment management systems or act as a stand-alone solution. All Paysign cards are accepted anywhere Visa, Interlink, Plus, MasterCard,

Maestro, Cirrus, Discover and Pulse are accepted depending on the brands used.

Key benefits of our corporate incentive cards

are:

Per Diem/ Corporate Expense Payments

Per Diem, Corporate Expense and Business Travel

Cards are reloadable prepaid card that allows businesses, non –profits and government agencies the ability to control employee spending

while reducing administration costs by eliminating the need for traditional expense reports. We are currently focusing on marketing these

card products to large corporations.

Pharmaceutical

Market

Our Paysign solutions for the pharmaceutical industry

are a specialized, adjudicated solution that pays all or a portion of a patient’s out-of-pocket costs associated with a prescription

drug purchase. Funds are provided by the sponsoring pharmaceutical company for use at retail pharmacies, specialty pharmacies, hospitals,

doctors’ offices and clinics nationwide.

Our pharmaceutical solutions provide payment claims

processing and other administrative services for clients according to client benefit plan designs. Our offerings also allow clients to

directly manage more of their pharmacy benefits and include pharmacy claims adjudication, network and payment administration, client call

center service and support, reporting, rebate management, as well as implementation, training and account management.

Patient Affordability Products and Services

Paysign provides targeted products and services

designed to address financial barriers related to patients starting and remaining on brand name drug therapies. Our products are specifically

designed to work within the established workflow of the specific healthcare provider. These products can be used to cover all or a portion

of the patient’s financial responsibility. We continue to build out additional products as industry concerns continue to emerge

presenting new business opportunities. A critical component of all patient affordability products is the ability of a pharmaceutical manufacturer

to access and visualize data related to the performance of their affordability program, patient and prescriber behavior, and overall brand

growth on a commercially insured patient basis. To provide these insights, Paysign has data scientist and a team of analytic professionals

dedicated to these products and clients.

Pharmacy Based Voucher and

Copay Affordability Programs: Voucher and Copay programs have become an industry standard offering for pharmaceutical brands entering

a market or seeking to increase market share. These products are processed via the pharmacy transactional systems in accordance with established

standards. These products are the most common form of affordability programs and exist for almost every retail and specialty-based branded

pharmaceutical drug. Pharmacies process claims to one of Paysign’s chosen processors who grow and maintain their own individual

contractual networks. Claims may be submitted in the primary or secondary payor position where our processor will adjudicate the claim

in accordance with business rules defined by each client.

Medical Claims Based Affordability

Programs: These programs are similar to pharmacy-based products but utilize internal networks developed and maintained by Paysign. We

are a direct processor of these claims and conduct adjudication on an internal proprietary platform specifically designed to address the

needs of our clients and their unique business rules. Payments for processed claims are made directly to a healthcare provider using our

virtual debit card products. We differentiate ourselves with this specific product by offering accelerated adjudication and payments relative

to our competition. This results in providers having a stronger willingness to utilize our products versus our competitors.

Debit Based Affordability

Programs: We continue to utilize physical and virtual debit cards to address highly specific industry concerns related to patient affordability.

These issues include utilization of debit-based products to combat copay accumulators and maximizers, currently one of the largest threats

in the marketplace for pharmaceutical manufacturers.

Source Plasma Donor Payments

Plasma derived therapies are lifesaving treatments

used to treat various rare conditions. Plasma based therapies are manufactured using human plasma, which is the yellow liquid portion

of whole blood that can be easily replaced by the body. Plasma makes up approximately 55% of whole blood and consists primarily of water

and proteins. Source plasma is the plasma collected from individual donors that serves as the raw material for the further manufacture

into these life saving therapies. Historically, source plasma donation centers compensated their donors with cash or checks. Over the

past several years, plasma donation centers have migrated to a prepaid card solution for donor payments.

The Company offers a comprehensive customized

payment solution for source plasma collection centers under the Paysign brand. The solution consists of the Paysign Plasma Donor Compensation

Prepaid Card, the Paysign Partner Portal for administrators, and the Paysign Kiosk. The Company recently introduced a number of enhancements

to its Plasma solution, offering cardholders a point-of-sale cash back rewards program, a pharmacy prescription discount card and a digital

bank account to assist our Pharma clients in their efforts to maximize the donor experience. The solution offers customized reporting

and provides a level of business analytics previously unavailable. The solution can be utilized either as a stand-alone web-based solution

or integrated with existing donor management systems, giving plasma donation centers an increased level of flexibility. The Company entered

the market in late 2011 and has seen significant growth in this market segment. Currently, the Company services approximately 35% of the

plasma collection centers in the United States.

DDA Debit Cards—Paysign Premier

Recently, providers of GPR card products, in response

to changes in the regulatory environment, have introduced new products similar to a GPR card but that act as true demand deposit accounts

accessible with a debit card (“DDA Debit Card”). These DDA Debit Cards offer many of the features and functionalities of a

traditional debit card associated with a standard bank account, including overdraft protection. The Company began marketing its DDA Debit

Card, branded Paysign Premier Digital Bank Account, in the third quarter of 2019. The Company markets this product to a targeted portion

of its existing cardholder base through existing communication points and to customers and employees of new clients.

Other Services

Customer Service Center

In order to provide a full range of services to

our customers, we offer a fully staffed, in-house Customer Service Center which is operational 24 hours a day, 7 days per week consisting

of live bilingual customer care representatives. The Paysign platform provides IVR, SMS alerts and two-way SMS messaging, allowing cardholders

to set alerts and check their balances and transaction history without the assistance of a live customer service operator. We believe

our in-house customer service center provides the highest quality customer service experience for our clients as training is performed

on-site by Paysign staff.

The Paysign Communications Suite

To help maximize the cardholder experience, cardholders

can access their card balances and transaction history, as well as other information as dictated by the program, such as an ATM locator,

a loyalty point counter, and geo-specific messaging through a number of touchpoints such as the Paysign kiosk, the Paysign Mobile App,

two-way SMS, text alerts and the Paysign cardholder web portal.

Technology

Our technology platform employs a standard enterprise

services bus in a service-oriented architecture, configured for 24/7/365 transaction processing and operations. We utilize two secure,

interconnected, environmentally-controlled data centers, with emergency power generation capabilities, and fully redundant capabilities.

We use a variety of proprietary and licensed standards-based technologies to implement our platforms, including those which provide for

orchestration, interoperability and process control. The platforms also integrate a data infrastructure to support both transaction processing

and data warehousing for operational support and data analytics.

Competition

The markets for financial products and services,

including prepaid cards and services related thereto, are intensely competitive. We compete with a variety of companies in our markets

and our competitors vary in size, scope and breadth of products and services offered. Certain segments of the financial services and healthcare

industries tend to be highly fragmented, with numerous companies competing for market share. Highly fragmented segments currently include

financial account processing, customer relationship management solutions, electronic funds transfer and prepaid solutions.

Many of our existing and potential competitors

have longer operating histories, greater financial strength and more recognized brands in the industry. These competitors may be able

to attract customers more easily because of their financial resources and awareness in the market. Our larger competitors can also devote

substantially more resources to business development and may adopt more aggressive pricing policies. To compete with these companies,

we rely primarily on direct marketing strategies including strategic marketing partners.

Sales and Marketing

We market our Paysign payment solutions through

direct marketing by the Company’s sales team. Our primary market focus is on companies and municipalities that require a streamlined

payment solution for rewards, rebates, payment assistance, and other payments to their customers, employees, agents and others. To reach

these markets, we focus our sales efforts on direct contact with our target market and attendance at various industry specific conferences.

We may, at times, utilize independent contractors who make direct sales and are paid on a commission basis only.

We market our Paysign Premier product through

existing communication channels to a targeted segment of our existing cardholders, as well as to a broad group of individuals, ranging

from non-banked to fully banked consumers with a focus on long term users of our product.

Markets and Major Customers

We have no major customers and are not reliant

on any individual card program. We manage multiple programs at any given time. As of December 31, 2021, we managed approximately

440 card programs with approximately 4.3 million participating cardholders.

Implications of Being an Emerging Growth Company

Paysign qualifies as an “emerging growth

company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage

of reduced reporting requirements that are otherwise applicable to public companies. These provisions include, but are not limited to:

We have elected to take advantage of certain reduced

disclosure obligations in this Annual Report on Form 10-K and may elect to take advantage of other reduced reporting requirements in future

filings. As a result, the information that we provide to our stockholders may be different from what you might receive from other public

reporting companies in which you hold equity interests.

In addition, under the JOBS Act, emerging growth

companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have

elected to avail ourselves of this exemption and, as a result, our financial statements may not be comparable to the financial statements

of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies.

Section 107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is

irrevocable.

We will remain an emerging growth company until

the earliest to occur of: (i) the last day of the first fiscal year in which our annual gross revenues exceed $1.07 billion;

(ii) the last day of 2024; (iii) the date that we become a “large accelerated filer” as defined in Rule 12b-2

under the Securities Exchange Act of 1934, as amended (referred to as the Exchange Act), which would occur if the market value of our

common equity held by non-affiliates exceeds $700.0 million as of the last business day of our most recently completed second fiscal

quarter; or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during any three-year

period.

Regulations

Introduction

We operate in a highly regulated environment and

are subject to extensive regulation, supervision and examination. Applicable laws and regulations may change, and there is no assurance

that such changes will not adversely affect our business. Regulatory authorities have extensive discretion in connection with their supervisory

and enforcement activities, including but not limited to the imposition of restrictions on the operation of financial institutions we

may work with. Any change in such regulation and oversight, whether in the form of restrictions on activities, regulatory policy, regulations,

or legislation, including but not limited to changes in the regulations governing banks, could have a material impact on our operations.

Our products and services are generally subject

to federal, state and local laws and regulations, including:

· anti-money laundering laws;

· money transfer and payment instrument licensing regulations;

· escheatment laws;

· privacy and information safeguard laws;

· bank regulations;

· consumer protection laws;

· false claims laws and other fraud and abuse restrictions; and

These laws are often evolving and sometimes ambiguous

or inconsistent, and the extent to which they apply to us or the banks that issue our cards, our clients or our third-party service providers

is at times unclear. Any failure to comply with applicable law — either by us or by the card issuing banks, our client or our

third-party service providers, over which we have limited legal and practical control — could result in restrictions on our

ability to provide our products and services, as well as the imposition of civil fines and criminal penalties and the suspension or revocation

of a license or registration required to sell our products and services. See "Risk Factors" for additional discussion regarding

the potential impacts of changes in laws and regulations to which we are subject and failure to comply with existing or future laws

and regulations.

We continually monitor and enhance our compliance

program to stay current with the most recent legal and regulatory changes. We also continue to implement policies and programs and to

adapt our business practices and strategies to help us comply with current legal standards, as well as with new and changing legal requirements

affecting particular services or the conduct of our business generally.

Anti-Money Laundering Laws

Our products and services are generally subject

to federal anti-money laundering laws, including the Bank Secrecy Act, as amended by the USA PATRIOT Act, and similar state laws. On an

ongoing basis, these laws require us, among other things, to:

· report large cash transactions and suspicious activity;

· gather and, in certain circumstances, report customer information;

· comply with consumer disclosure requirements; and

Anti-money laundering regulations are constantly

evolving. We continuously monitor our compliance with anti-money laundering regulations and implement policies and procedures to make

our business practices flexible, so we can comply with the most current legal requirements. We cannot predict how these future regulations

might affect us. Complying with future regulation could be expensive or require us to change the way we operate our business.

Money Transfer and Payment Instrument Licensing

Regulations

We are not currently subject to money transfer

and payment instrument licensing regulations; however, we have plans to introduce products in the future that would be subject to such

regulations. Currently, we believe that 39 U.S. jurisdictions would require us to obtain a license to operate a money transfer business.

As a licensee, we would be subject to certain restrictions and requirements, including reporting, net worth and surety bonding requirements

and requirements for regulatory approval of controlling stockholders, agent locations and consumer forms and disclosures. We would also

be subject to inspection by the regulators in the jurisdictions in which we are licensed, many of which conduct regular examinations.

In addition, we would be required to maintain "permissible investments" in an amount equivalent to all "outstanding payment

obligations."

Escheatment Laws

Unclaimed property laws of every U.S. state require that certain information be tracked on card programs.

If customer funds are unclaimed at the end of an applicable statutory abandonment period, the proceeds of the unclaimed property must

be remitted to the appropriate state. Analysis of facts and circumstances of each card program under state unclaimed property laws

determines whether funds under such programs are escheatable.

Privacy and Information Safeguard Laws

In the ordinary course of our business, we or

our third-party service providers collect certain types of data, which subjects us to certain privacy and information security laws in

the United States, including, for example, the Gramm-Leach-Bliley Act of 1999, and other laws or rules designed to regulate consumer information

and mitigate identity theft. We are also subject to privacy laws of various states. These state and federal laws impose obligations with

respect to the collection, processing, storage, disposal, use and disclosure of personal information, and require that financial institutions

have in place policies regarding information privacy and security. In addition, under federal and certain state financial privacy laws,

we must provide notice to consumers of our policies and practices for sharing nonpublic information with third parties, provide advance

notice of any changes to our policies and, with limited exceptions, give consumers the right to prevent use of their nonpublic personal

information and disclosure of it to unaffiliated third parties. Certain state laws may, in some circumstances, require us to notify affected

individuals of security breaches of computer databases that contain their personal information. These laws may also require us to notify

state law enforcement, regulators or consumer reporting agencies in the event of a data breach, as well as businesses and governmental

agencies that own data. In order to comply with the privacy and information safeguard laws, we have confidentiality/information security

standards and procedures in place for our business activities and with our third-party vendors and service providers. Privacy and information

security laws evolve regularly, requiring us to adjust our compliance program on an ongoing basis and presenting compliance challenges.

Bank Regulations

All of the cards that we service are issued by

a state-chartered bank. Thus, we are subject to the oversight of the regulators for, and certain laws applicable to, these card issuing

banks. These banking laws require us, as a servicer to the banks that issue our cards, among other things, to undertake compliance actions

similar to those described under "Anti-Money Laundering Laws" above and to comply with the privacy regulations promulgated under

the Gramm-Leach-Bliley Act as discussed under "Privacy and Information Safeguard Laws" above.

Consumer Protection Laws

Certain products that we anticipate introducing

in the future will likely be subject to additional state and federal consumer protection laws, including laws prohibiting unfair and deceptive

practices, regulating electronic fund transfers and protecting consumer nonpublic information. Before we can introduce those products,

we will have to develop appropriate procedures for compliance with these consumer protection laws.

Card Networks

In order to provide our products and services,

we, as well as the banks that issue our cards, must be registered with Visa and/or MasterCard, as well as any other networks that we desire

to use, such as Interlink, Plus, Maestro, Cirrus, Discover and Pulse, and, as a result, are subject to card association rules that could

subject us to a variety of fines or penalties that may be levied by the card association or network for certain acts or omissions. The

banks that issue our cards are specifically registered as "members" of the card networks. The card networks set the standards

with which we and the card issuing banks must comply.

False Claims Laws and Other Fraud and Abuse

Restrictions

We provide claims processing and other transaction

services to pharmaceutical companies that relate to, or directly involve, the reimbursement of pharmaceutical costs covered by Medicare,

Medicaid, other federal healthcare programs and private payers. As a result of these aspects of our business, we may be subject to, or

contractually required to comply with, state and federal laws that govern various aspects of the submission of healthcare claims for reimbursement

and the receipt of payments for healthcare items or services. These laws generally prohibit an individual or entity from knowingly presenting

or causing to be presented claims for payment to Medicare, Medicaid or other third-party payers that are false or fraudulent. False or

fraudulent claims include, but are not limited to, billing for services not rendered, failing to refund known overpayments, misrepresenting

actual services rendered in order to obtain higher reimbursement, improper coding and billing for medically unnecessary goods and services.

Many of these laws provide significant civil and criminal penalties for noncompliance and can be enforced by private individuals through

“whistleblower” or qui tam actions. To avoid liability, providers and their contractors must, among other things, carefully

and accurately code, complete and submit claims for reimbursement.

From time to time, participants in the healthcare

industry, including us, may be subject to actions under the federal False Claims Act or other fraud and abuse provisions. We cannot guarantee

that state and federal agencies will regard any billing errors we process as inadvertent or will not hold us responsible for any compliance

issues related to claims we handle on behalf of providers and payers. Although we believe our editing processes are consistent with applicable

reimbursement rules and industry practice, a court, enforcement agency or whistleblower could challenge these practices. We cannot predict

the impact of any enforcement actions under the various false claims and fraud and abuse laws applicable to our operations. Even an unsuccessful

challenge of our practices could cause adverse publicity and cause us to incur significant legal and related costs.

Privacy and Security Standards under HIPAA

or Other Laws.

The Health Insurance Portability and Accountability

Act of 1996 contains privacy regulations and the security regulations that apply to some of our operations. The privacy regulations extensively

regulate the use and disclosure of individually identifiable health information by entities subject to HIPAA. For example, the privacy

regulations permit parties to use and disclose individually identifiable health information for treatment and to process claims for payment,

but other uses and disclosures, such as marketing communications, require written authorization from the individual or must meet an exception

specified under the privacy regulations. The privacy regulations also provide patients with rights related to understanding and controlling

how their health information is used and disclosed. To the extent permitted by the privacy regulations from the American Recovery and

Reinvestment Act, and our contracts with our customers, we may use and disclose individually identifiable health information to perform

our services and for other limited purposes, such as creating de-identified information. Determining whether data has been sufficiently

de-identified to comply with the privacy regulations and our contractual obligations may require complex factual and statistical analyses

and may be subject to interpretation. The security regulations require certain entities to implement and maintain administrative, physical

and technical safeguards to protect the security of individually identifiable health information that is electronically transmitted or

electronically stored. We have implemented and maintain policies and processes to assist us in complying with the privacy regulations,

the security regulations and our contractual obligations. We cannot provide assurance regarding how these standards will be interpreted,

enforced or applied to our operations. If we are unable to properly protect the privacy and security of health information entrusted to

us, we could be subject to substantial penalties, damages and injunctive relief.

In addition to HIPAA, numerous other state and

federal laws govern the collection, dissemination, use, access to and confidentiality of individually identifiable health information

and healthcare provider information. In addition, some states are considering new laws and regulations that further protect the confidentiality,

privacy and security of medical records or other types of medical information. In many cases, these state laws are not preempted by the

HIPAA privacy regulations and may be subject to interpretation by various courts and other governmental authorities. Further, the U.S. Congress

and a number of states have considered or are considering prohibitions or limitations on the disclosure of medical or other information

to individuals or entities located outside of the United States.

Patents and Trademarks

We protect our intellectual property rights through

a combination of trademark, patent, copyright, and trade secrets laws.

In order to limit access to and disclosure of

our intellectual property and proprietary information, all of our employees and consultants have signed confidentiality and we enter into

nondisclosure agreements with third parties. We cannot provide assurance that the steps we have taken to protect our intellectual property

rights, however, will deter adequately infringement or misappropriation of those rights. Particularly given the international nature of

the Internet, the rate of growth of the Internet and the ease of registering new domain names, we may not be able to detect unauthorized

use of our intellectual property or proprietary information, or to take enforcement action.

Employees and Independent Contractors

As of December 31, 2021, we had approximately

eighty employees and independent contractors.

We have no collective bargaining agreements with

our employees, and believe all independent contractor and employment agreement relationships are satisfactory. We hire independent contractors

on an as-needed basis, and we may retain additional employees and consultants during the next twelve months, including additional executive

management personnel with substantial experience in development business.

Available Information

Our internet address is www.paysign.com. Information

on our website does not constitute part of this Annual Report.

ITEM

1A. RISK FACTORS.

An investment in our common stock involves

a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information

in this Form 10-K, including our consolidated financial statements and related notes. If any of the following risks actually occurs, our

business, financial condition, results of operations and future prospects could be materially and adversely affected. In that event, the

market price of our common stock could decline and you could lose part or all of your investment. All forward-looking statements made

by us or on our behalf are qualified by the risks described below.

Risks Related to Our Business

We may be unable to grow our business in future

periods, and if our revenue growth slows, or our revenues decline further, our business and financial conditions could be adversely affected.

Our growth rates may decline in the future. There

can be no assurance that we will be able to grow our business in future periods. In the near term, our growth depends in significant part

on our ability, among other things, to enter new markets and to continue to attract new clients, and to retain our current clientele.

Our growth also depends on our ability to develop and market other prepaid card products that can utilize the Paysign platform.

As the prepaid financial services industry continues

to develop, our competitors may be able to offer products and services that are, or that are perceived to be, substantially similar to

or better than ours. This may force us to compete on the basis of price and to expend significant marketing, product development and other

resources in order to remain competitive. Even if we are successful at increasing our operating revenues through our various initiatives

and strategies, we will experience an inevitable decline in growth rates as our operating revenues increase to higher levels and we may

also experience a decline in margins. If our operating revenue growth rates slow materially or decline, our business, operating results

and financial condition could be adversely affected.

As a result of the COVID-19 pandemic, our business, financial condition,

profitability, and cash flows have been, and are likely to continue to be, negatively impacted.

The coronavirus (COVID-19) pandemic, which started

in late 2019 and reached the United States in early 2020, continues to significantly impact the economy of the United States and the rest

of the world. Federal, state and local authorities in the United States imposed measures intended to reduce the spread of the virus, including

restrictions on freedom of movement and business operations such as travel bans, business limitations and closures, quarantines and shelter-in-place

orders. These measures had a significant impact on the global economy and financial markets, and adversely affected the demand for our

products and services. While the disruption appears to be mitigating due to the availability of vaccines and other factors, the ultimate

duration and severity of the pandemic remain uncertain, particularly given the development of new variants that continue to spread. The

COVID-19 outbreak caused plasma center closures, and the stimulus packages signed into law during 2020 and 2021 reduced the incentive

for individuals to donate plasma for supplementary income. Those developments have had and will continue to have an adverse impact on

the Company’s results of operations. While we remain cautiously optimistic and have seen improvements in our operating results,

we cannot foresee how long it may take the Company to attain pre-pandemic operating levels as COVID-19 related labor shortages at plasma

donation centers, border closures, and other effects continue to weigh on the Company’s results of operations. Given the uncertainty

around the extent and timing of the potential future spread or mitigation of COVID-19 and variants and around the imposition or relaxation

of protective measures, management cannot at this time estimate with reasonable accuracy COVID-19’s further impact on the Company’s

results of operations, cash flows or financial condition.

We operate in a highly regulated environment, and failure by us

or business partners to comply with applicable laws and regulations could have an adverse effect on our business, financial position and

results of operations.

We operate in a highly regulated environment,

and failure by us or our business partners to comply with the laws and regulations to which we are subject could negatively impact our

business. We are subject to a wide range of federal and other state laws and regulations, which are described under "Business – Regulations"

above. In particular, our products and services are subject to an increasingly strict set of legal and regulatory requirements intended

to protect consumers and to help detect and prevent money laundering, terrorist financing and other illicit activities.

Many of these laws and regulations are evolving,

unclear and inconsistent across various jurisdictions, and ensuring compliance with them is difficult and costly. For example, with increasing

frequency, federal and state regulators are holding businesses like ours to higher standards of training, monitoring and compliance, including

monitoring for possible violations of laws by the businesses that participate in our reload network. Failure by us or those businesses

to comply with the laws and regulations to which we are subject could result in fines, penalties or limitations on our ability to conduct

our business, or federal or state actions, any of which could significantly harm our reputation with consumers and other network participants,

banks that issue our cards and regulators, and could materially and adversely affect our business, operating results and financial condition.

Changes in the laws, regulations, credit card association rules

or other industry standards affecting our business may impose costly compliance burdens and negatively impact our business.

There may be changes in the laws, regulations,

card association rules or other industry standards that affect our operating environment in substantial and unpredictable ways. Changes

to statutes, regulations or industry standards, including interpretation and implementation of statutes, regulations or standards, could

increase the cost of doing business or affect the competitive balance. For example, more stringent anti-money laundering regulations could

require the collection and verification of more information from our customers, which could have a material adverse effect on our operations.

Regulation of the payments industry has increased significantly in recent years. A number of regulations impacting the credit card industry

were recently implemented. Additional changes may require us to incur significant expenses to redevelop our products. Also, failure to

comply with laws, rules and regulations or standards to which we are subject, including with respect to privacy and data use and security,

could result in fines, sanctions or other penalties, which could have a material adverse effect on our financial position and results

of operations, as well as damage our reputation.

A data security breach could expose us to liability and protracted

and costly litigation, and could adversely affect our reputation and operating results.

We, the banks that issue our cards and our third-party

service providers receive, transmit and store confidential customer and other information in connection with our products and services.

The encryption software and the other technologies we and our partners use to provide security for storage, processing and transmission

of confidential customer and other information may not be effective to protect against data security breaches. The risk of unauthorized

circumvention of our security measures has been heightened by advances in computer capabilities and the increasing sophistication of hackers.

The banks that issue our cards, our clients and our third-party service providers also may experience similar security breaches involving

the receipt, transmission and storage of our confidential customer and other information. Improper access to our or these third parties'

systems or databases could result in the theft, publication, deletion or modification of confidential customer and other information.

A data security breach of the systems on which

sensitive cardholder data and account information are stored could lead to fraudulent activity involving our products and services, reputational

damage and claims or regulatory actions against us. If we are sued in connection with any data security breach, we could be involved in

protracted and costly litigation. If unsuccessful in defending that litigation, we might be forced to pay damages and/or change our business

practices or pricing structure, any of which could have a material adverse effect on our operating revenues and profitability. We would

also likely have to pay (or indemnify the banks that issue our cards for) fines, penalties and/or other assessments imposed by card networks

as a result of any data security breach. Further, a significant data security breach could lead to additional regulation, which could

impose new and costly compliance obligations. In addition, a data security breach at one of the banks that issue our cards or our third-party

service providers could result in significant reputational harm to us and cause the use and acceptance of our cards to decline, either

of which could have a significant adverse impact on our operating results and future growth prospects.

We may have deficiencies or weaknesses in our internal control over

financial reporting which could, if not remediated, adversely affect our ability to report our financial condition and results of operations

in a timely and accurate manner, decrease investor confidence in our Company, and reduce the value of our common stock.

Our management is responsible for establishing

and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act

and based upon the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations

of the Treadway Commission (the “COSO framework”). Management is also responsible for reporting on the effectiveness of internal

control over financial reporting.

Deficiencies or weaknesses in our internal control

over financial reporting that are not promptly identified and remediated may adversely affect our ability to report our financial condition

and results of operations in a timely and accurate manner, decrease investor confidence in our Company, and reduce the value of our common

stock. Although we believe we have taken appropriate actions to remediate previously reported control deficiencies that we have identified

and to strengthen our internal control over financial reporting, we cannot assure you that we will not discover other deficiencies or

weaknesses in the future.

Security and privacy breaches of our electronic

transactions may damage customer relations and inhibit our growth.

Any failures in our security and privacy measures

could have a material adverse effect on our business, financial condition and results of operations. Certain products we offer require

that we store personal information, including birth dates, addresses, bank account numbers, credit card information, social security numbers

and merchant account numbers. If we are unable to protect this information, or if consumers perceive that we are unable to protect this

information, our business and the growth of the electronic commerce market in general could be materially adversely affected. A security

or privacy breach may:

Source: SEC EDGAR (public domain) · 10-K for the period ended 2021-12-31, filed 2022-03-23 · accession 0001683168-22-001854

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 16 headings are on that chain and 2 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.